Hemodialysis-associated amyloidosis: Causes, Symptoms and Treatment

Written by Medicover Team and Medically Reviewed by Dr Pavan Wakhare , Nephrologists

Hemodialysis-associated amyloidosis is a complication of long-term dialysis caused by the buildup of beta-2 microglobulin protein in the joints, bones, and surrounding tissues. It commonly causes joint pain, stiffness, carpal tunnel syndrome, and reduced mobility. Early diagnosis and appropriate treatment, including improved dialysis techniques or kidney transplantation, help relieve symptoms, slow disease progression, and improve quality of life.

What Are the Symptoms of Hemodialysis-associated amyloidosis?

Hemodialysis-associated amyloidosis can cause symptoms like joint pain, stiffness, and swelling, especially in the shoulders, wrists, and hips. Patients may also experience carpal tunnel syndrome, leading to numbness and tingling in the hands and fingers.

Additionally, individuals with this condition may develop thickened and stiff joints, making movement difficult and painful. Skin changes such as easy bruising and a waxy appearance are common in hemodialysis-associated amyloidosis. If you are undergoing hemodialysis and notice these symptoms, it's essential to consult your healthcare provider for proper evaluation and management.

What are the Causes of Hemodialysis-associated amyloidosis?

The process begins when beta 2M, a protein normally eliminated by the kidneys, builds up in the bloodstream due to impaired renal function. In hemodialysis patients, the dialysis procedure is unable to effectively remove beta 2M, leading to its deposition in tissues such as joints and tendons. Over time, this accumulation can trigger an inflammatory response, ultimately resulting in the development of amyloid deposits and the associated symptoms of amyloidosis.

When to See a Doctor for Hemodialysis-associated amyloidosis?

Consult a nephrologists if you have been receiving long-term dialysis and develop persistent joint pain, stiffness, numbness in the hands, or reduced mobility. Early evaluation can help prevent permanent joint damage and improve function.

You should see a doctor if you have:

Get medical help immediately if:

These could indicate serious complications requiring urgent medical care.

Find Nephrologists for Hemodialysis Associated Amyloidosis Treatment Near You

How is Hemodialysis-associated amyloidosis Diagnosed?

Hemodialysis-associated amyloidosis is diagnosed through a combination of clinical evaluation, imaging studies, and laboratory tests. Patients undergoing hemodialysis who present with symptoms such as joint pain, swelling, and limited range of motion should be evaluated. Imaging studies like X-rays and MRI can help identify amyloid deposits in joints.

Blood tests may reveal elevated inflammatory markers and abnormal levels of certain proteins associated with amyloidosis. In some cases, a biopsy of affected tissue may be necessary to confirm the presence of amyloid deposits. An interdisciplinary approach involving nephrologists, rheumatologists, and pathologists is typically employed to reach a definitive diagnosis and initiate appropriate management.

What Are the Treatment Options for Hemodialysis-associated amyloidosis?

Hemodialysis-associated amyloidosis treatment focuses on managing symptoms and slowing disease progression. Options may include medications to reduce inflammation and pain, dietary changes to limit protein intake, and dialysis adjustments to minimize amyloid protein build-up. In some cases, surgery may be necessary to address complications like carpal tunnel syndrome.

Physical therapy and regular monitoring are essential for maintaining quality of life. Collaborating closely with a healthcare team can help tailor a comprehensive treatment plan that addresses individual needs and improves overall well-being for those affected by hemodialysis-associated amyloidosis.

Hemodialysis-associated amyloidosis, a condition characterized by the accumulation of amyloid proteins in the joints and tendons, can be managed through various treatment options. One approach is to optimize the hemodialysis treatment itself, ensuring adequate clearance of uremic toxins and maintaining proper fluid balance to reduce the burden on the kidneys. Physical therapy and regular exercise can help improve joint mobility and reduce pain associated with amyloid deposits. In some cases, surgical intervention may be necessary to address severe joint damage caused by amyloidosis.

Your health is everything - prioritize your well-being today.

Consult Hemodialysis Associated Amyloidosis Doctors Today

What are the Risk Factors for Hemodialysis-associated amyloidosis?

Risk factors for developing this condition include the duration of hemodialysis treatment, with a higher risk associated with longer treatment periods. Additionally, older age, genetic predisposition, and certain types of dialysis membranes have been linked to an increased risk of hemodialysis-associated amyloidosis. Proper monitoring and management of these risk factors are essential in reducing the likelihood of developing this condition in hemodialysis patients.

What Is the Recovery Process for Hemodialysis-associated amyloidosis?

Recovery focuses on managing symptoms and maintaining quality of life.